InvestorsHub Logo
Followers 237
Posts 10817
Boards Moderated 0
Alias Born 07/17/2006

Re: dmlcento post# 118162

Tuesday, 11/21/2017 3:55:57 PM

Tuesday, November 21, 2017 3:55:57 PM

Post# of 423561
dml

quote: "I hope this isn't there way of saying the results aren't going to be real good."

Absolutely not...

Here is the crux of CG's article on pragmatic therapy.

"here are five tenets of pragmatic therapy:

1. Proven efficacy

2. Proven safety in clinical trials and real-world practice

3. Ease of use – tolerability, few drug-drug interactions, no complex dosing or method of delivery

4. Reasonable cost to the payer and to patients

5. Easy adaptability to a physician’s current practice patterns'"

I can't think of a single FDA drug approved in the last ten years that conforms to CG's tenet more than Vascepa...Anyone who watches TV is familiar
with the direct marketing ads on drugs...15 seconds on what the drug cures 45 minutes on the adverse effects...including the fatal ones...Vascepa beats them all by a mile...Vascepa will be the poster child for all drugs...

":>) JL
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News